The IV STING agonist, TAK-676, enhances immune-mediated anti-tumor activity of radiation in syngeneic mouse models

被引：0
|
作者：
Appleman, Vicky A. [1 ]
Berger, Allison J. [1 ]
Roberts, Emily R. [1 ]
Maldonado-Lopez, Angel E. [1 ]
Ganno, Michelle L. [1 ]
Christensen, Camilla I. [1 ]
Hatten, Tiquella [1 ]
Sato, Yosuke [1 ]
Shaw, Michael H. [1 ]
Malek, Karim S. [1 ]
Lineberry, Neil B. [1 ]
Abu-Yousif, Adnan O. [1 ]
Gregory, Richard C. [1 ]
机构：
[1] Takeda Dev Ctr Amer Inc TDCA, Lexington, MA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3448
引用
收藏
页数：1
相关论文
共 47 条
  • [31] Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Budha, Sadnu
    Giese, Rachel
    Gupta, Aditi
    De Henau, Olivier
    Zappasodi, Roberta
    Campesato, Luis Felipe
    Barker, Christopher
    Shan, Joseph
    Wolchok, Jedd D.
    Merghoub, Taha
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [32] Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Budhu, Sadna
    De Henau, Olivier
    Zappasodi, Roberta
    Giese, Rachel
    Campesato, Luis F.
    Barker, Christopher
    Freimark, Bruce
    Hutchins, Jeff
    Wolchok, Jedd D.
    Merghoub, Taha
    CANCER RESEARCH, 2017, 77
  • [33] Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Budhu, Sadna
    Giese, Rachel
    De Henau, Olivier
    Zappasodi, Roberta
    Campesato, Luis Felipe
    Gupta, Aditi
    Barker, Christopher
    Freimark, Bruce
    Wolchok, Jedd D.
    Merghoub, Taha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [34] Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack
    Cacan, Ercan
    Spring, Alexander M.
    Kumari, Anita
    Greer, Susanna F.
    Garnett-Benson, Charlie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (12): : 30405 - 30421
  • [35] Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models
    Kandaswamy, Veena
    Forest, Amelie
    Deroose, Marianne
    Schaer, David A.
    Chen, Ting
    Liu, Shengwu
    Surguladze, David
    Yao, Yung-mae
    Doman, Thompson
    Hall, Gerald
    Wong, Kwok-Kin
    Kalos, Michael
    Novosiadly, Ruslan D.
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Combined Radiation and PI3Kgd Inhibitor Enhances Anti-Tumor Effect of PD-1 Blockade in Immune-competent Syngeneic Breast Cancer Model
    Han, M. G.
    Jang, B. S.
    Kang, M. H.
    Chang, W. I.
    Kim, I. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S109 - S110
  • [37] Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
    Naoto Kunimura
    Koichi Kitagawa
    Ryota Sako
    Keita Narikiyo
    Shoko Tominaga
    Diosdado S. Bautista
    Wei Xu
    Masato Fujisawa
    Toshiro Shirakawa
    Scientific Reports, 10
  • [38] Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
    Kunimura, Naoto
    Kitagawa, Koichi
    Sako, Ryota
    Narikiyo, Keita
    Tominaga, Shoko
    Bautista, Diosdado S.
    Xu, Wei
    Fujisawa, Masato
    Shirakawa, Toshiro
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] XMT-2056, a well-tolerated, Immunosynthen-based STING-agonist antibody-drug conjugate which induces anti-tumor immune activity.
    Duvall, Jeremy R.
    Bukhalid, Raghida A.
    Cetinbas, Naniye M.
    Catcott, Kalli C.
    Slocum, Kelly
    Avocetien, Kenneth
    Bentley, Keith W.
    Bradley, Stephen
    Clardy, Susan
    Collins, Scott D.
    Ditty, Elizabeth
    Eitas, Timothy
    Jones, Brian D.
    Kelleher, Eugene W.
    Lee, Winnie
    Monnell, Travis
    Mosher, Rebecca
    Protopopova, Marina
    Qin, LiuLiang
    Shaw, Pamela
    Ter-Ovanesyan, Elena
    Thomas, Joshua D.
    Wongthida, Phonphimon
    Xu, Ling
    Yang, Liping
    Zurita, Jeffrey
    Toader, Dorin
    Damelin, Marc
    Lowinger, Timothy B.
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Intra-tumoral immune cell mobilization and anti-tumor activity after treatment with the engineered cytokine NKTR-214 in multiple preclinical mouse tumor models
    Charvch, D.
    Hennessy, M.
    Langowski, J.
    Dixit, V.
    Rubas, W.
    Hoch, U.
    Pena, R.
    Quach, P.
    Doberstein, S. K.
    Zaleveky, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S101 - S101
12345